EP 1720899 A2 20061115 - MULTIMERISED HIV FUSION INHIBITORS
Title (en)
MULTIMERISED HIV FUSION INHIBITORS
Title (de)
MULTIMERISIERTE HIV-FUSIONSINHIBITOREN
Title (fr)
INHIBITEURS DE FUSION DU VIH MULTIMERISES
Publication
Application
Priority
- DK 2005000121 W 20050223
- DK PA200400283 A 20040223
- US 54620004 P 20040223
Abstract (en)
[origin: WO2005080418A2] There are provided multimeric fusion proteins exhibiting anti-viral activity. The fusion proteins comprise the HR2 region of the ectodomain of the human immunodeficiency virus gp41 protein which is fused to a multimerisation domain peptide such as a trimerisation domain derived from tetranectin. The multimerised fusion proteins may be used as HIV fusion inhibitors in the treatment of AIDS.
IPC 8 full level
C07K 14/16 (2006.01); A61K 38/16 (2006.01); A61K 39/00 (2006.01); A61P 31/18 (2006.01); C07K 14/47 (2006.01); C07K 19/00 (2006.01); C12N 5/10 (2006.01); C12N 15/49 (2006.01); C12N 15/62 (2006.01); C12N 15/63 (2006.01)
CPC (source: EP)
A61P 31/18 (2017.12); C07K 14/005 (2013.01); C07K 2319/31 (2013.01); C12N 2740/16122 (2013.01)
Citation (search report)
See references of WO 2005080418A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005080418 A2 20050901; WO 2005080418 A3 20050922; BR PI0507949 A 20070724; EP 1720899 A2 20061115
DOCDB simple family (application)
DK 2005000121 W 20050223; BR PI0507949 A 20050223; EP 05706783 A 20050223